147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Applications
Therapy areas
More posts

Heln er beta cell line

The stably transfected luciferase reporter HELN Er alpha cell line (named HELN for HeLa-ERE-Luciferase-Neomycin) was obtained by transfection of ER […]

Heln er alpha cell line

Cervical cancer cell line HeLa (ER negative) firstly transfected by a luciferase firefly gene under the control of an estrogen responsive element […]

Tagged leptin receptors hek293t cells

Hek293T cells were transfected with short form human leptin receptors (OBR) tagged individually with either Rluc (pIRESpuro3, Clontech) or YFP […]

Rat mesothelial cell line m2-2

Transformed rat mesothelial cell line isolated from the peritoneal fluid of a male rat (Fischer F344) after 270 days of induction with crocidolite […]

Rat mesothelial cell line m2-3

Transformed rat mesothelial cell line isolated from the peritoneal fluid of a male rat (Fischer F344) after 284 days of induction with crocidolite […]

Rat mesothelioma cell line f5-t1

Neoplastic rat cell line isolated from tumor masses (peritoneal mesothelioma) collected in the peritoneal cavity of a female rat (F344) after 392 days […]

Rat mesothelioma cell line m5-t1

Neoplastic rat cell line isolated from tumor masses (peritoneal mesothelioma) collected in the peritoneal cavity of a male rat (F344) after 378 days […]

Rat mesothelial cell line m3-2

Transformed rat mesothelial cell line isolated from the peritoneal fluid of a male rat (Fischer F344) after 263 days of induction with crocidolite […]

More posts

You might also be interested in